ACLX Q1 2025 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-79.3% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$69M-847.6% margin

Net Income

-$62M-766.0% margin

EPS (Diluted)

$-1.13

QoQ Revenue Growth

-46.8%

Cash Flow

Operating Cash Flow

-$63M

Free Cash Flow

-$64M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$648M

Total Liabilities

$231M

Stockholders' Equity

$417M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$39M	-79.3%
Gross Profit	$8M	$38M	-78.8%
Operating Income	-$69M	-$16M	-335.8%
Net Income	-$62M	-$7M	-765.1%